J Korean Ophthalmol Soc > Volume 48(9); 2007 > Article
Journal of the Korean Ophthalmological Society 2007;48(9):1227-1233.
DOI: https://doi.org/10.3341/jkos.2007.48.9.1227    Published online September 30, 2007.
The Efficacy of Intravitreal Triamcinolone Acetonide Injection for Macular Edema in Central Retinal Vein Occlusion.
Su Yeon Kang, Moon Jeong Choi, Su Jin Yoo, Tae Gon Lee, Soon Hyun Kim
1Myung-Gok Eye Research Institute, Department of Ophthalmology, Konyang University, Kim's Eye Hospital, Seoul, Korea. nunekim@hotmail.com
2Nune Eye Hospital, Seoul, Korea.
망막중심정맥폐쇄환자에서 황반부종에 대한 유리체내 트리암시놀론주입술의 효과
강수연1,최문정1,유수진1,이태곤1,김순현2
Myung-Gok Eye Research Institute, Department of Ophthalmology, Konyang University, Kim`s Eye Hospital1, Seoul, Korea Nune Eye Hospital2, Seoul, Korea
Correspondence:  Soon Hyun Kim, M.D., Ph.D.
Abstract
PURPOSE
To investigate the effect of intravitreal injection of triamcinolone acetonide (IVTA) for the treatment of macular edema in central retinal vein occlusion (CRVO). METHODS: Seventy patients with CRVO and persistent macular edema were included in this retrospective study. Thirty-six eyes of 36 patients received an intravitreal injection of 4 mg (0.1 cc) triamcinolone and 34 eyes of 34 control patients didnot receive an injection. Any differences in visual acuity and foveal thickness were measured and compared between the two groups. The correlation between the change in foveal thickness and visual acuity was also evaluated. RESULTS: In ischemic CRVO group, the mean difference of visual acuity between the injection and the control groups was not statistically significant (p<0.05) at the initial measurement and at one week, one, three, and six months after the injection. However, in the non-ischemic CRVO group it was not clinically significant (p<0.05) at the initial time, one week or six months after the injection. But it was clinically significant at one months and three months after receiving the injection (p=0.004 and 0.001). The mean difference in foveal thickness was clinically significant (p<0.001). The visual acuity and foveal thickness were correlated in non-ischemic group but not in the ischemic group. CONCLUSIONS: The IVTA appears to be an effective treatment in patients with macular edema associated with CRVO. The visual acuity of patients with non-ischemic CRVO improved temporally after the IVTA injection, but there was no significant improvement in ischemic CRVO group.
Key Words: Central retinal vein occlusion;Intravitreal injection;Triamcinolone acetonide;Macular edema


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next